Lawriter - OAC - 4723-9-01 Definitions.

4723-9-01 Definitions.

For purposes of this chapter the following definitions shall apply:

(A) "Collaboration or collaborating" means in the case of a certified nurse practitioner, a clinical nurse specialist or a certified nurse-midwife, that a physician has entered into a standard care arrangement with the nurse and is continuously available to communicate with the nurse either in person, or by electronic communication .

(B) "Consultation" means the discussion or communication between a clinical nurse specialist, certified nurse-midwife, or certified nurse practitioner with a physician prior to initiating the prescription for a drug. The consultation relative to drug therapy shall be documented in the patient's record and shall include the consulting physician's name and the date the consultation took place.

(C) "Controlled substance" means a drug, compound, mixture, preparation, or substance included in schedule I, II, III, IV, or V pursuant to the provisions of Chapter 3719. of the Revised Code.

(D) "Contact hour" means a minimum of sixty minutes of continuing education. For credit hours earned on an academic quarter system, one credit hour is equivalent to ten contact hours. For credit hours earned on an academic trimester system, one credit hour is equivalent to twelve contact hours. For credit hours earned on an academic semester system, one credit hour is equivalent to fifteen contact hours.

(E) "Course of study" means an advanced level instructional program in pharmacology required by section 4723.482 of the Revised Code for advanced practice registered nursing licensure, that is either:

(1) Offered by an accredited educational institution acceptable to the board. Accredited educational institutions acceptable to the board include programs that are required to obtain approval, authorization, or accreditation from one of the following:

(a) The Ohio board of regents under section 3333.07 of the Revised Code;

(b) The Ohio department of education under section 3313.90 of the Revised Code;

(c) The Ohio state board of career colleges and schools under section 3332.05 of the Revised Code;

(d) The higher learning commission of the north central association of colleges and schools;

(e) The accrediting council for independent colleges and schools; or

(f) Any other national or regional post-secondary education accreditation entity recognized by the board; or

(2) A continuing education course that meets the requirements of Chapter 4723-14 of the Administrative Code.

(F) "Dangerous drug' has the same meaning as in section 4729.01 of the Revised Code.

(G) "Jurisdiction" means any state, territory, or political subdivision of the United States in which a board or legal approving authority regulates nurse licensure and nursing practice and maintains membership in the national council of state boards of nursing.

(H) "Physician" means an individual who holds a current valid license to practice medicine and surgery, osteopathic medicine and surgery, or podiatric medicine and surgery issued by the Ohio state medical board, or, in the case of applicants who hold a current valid certificate of authority to prescribe drugs and therapeutic devices from another jurisdiction, or who have been employed by the United States government and authorized to prescribe in conjunction with that employment, the physician's license may be issued by another jurisdiction as defined in this chapter.

(I) "Sample drug" has the same meaning as in section 2925.01 of the Revised Code.

(J) "Types of drugs" means therapeutic drug class.

Effective: 1/1/2018
Five Year Review (FYR) Dates: 10/15/2020
Promulgated Under: 119.03
Statutory Authority: 4723.50
Rule Amplifies: 4723.48, 4723.49, 4723.50
Prior Effective Dates: 10/01/2001, 02/01/2002, 02/01/2006, 02/01/2011, 11/05/2012, 02/01/2016